Governance

The Quadram Institute is a unique partnership bringing together four partners; the University of East Anglia, the Norfolk and Norwich University Hospitals NHS Foundation Trust, Quadram Institute Bioscience and the Biotechnology and Biological Sciences Research Council.

The Quadram Institute partnership was created to help harness world-class food, health and microbiome science, all housed in the state-of-the-art Quadram Institute which opened in 2018/19.

Our vision is to understand how food and microbes interact to promote health and prevent disease. By bringing together clinicians and researchers working in bioscience and genomics, through food and into human health, the Quadram creates a pipeline of research with the potential to create solutions with verified benefits for human health.

Quadram Institute Bioscience Leadership

Director of the Quadram Institute and Quadram Institute Bioscience

Professor Daniel Figeys is the Director of the Quadram Institute and Director and Chief Executive Officer of Quadram Institute Bioscience. He leads the programme to develop the Quadram Institute.

Prof Figeys joined the Quadram Institute in April 2025 as Director and moved to the institute from Canada, where he was Founding Director of the School of Pharmaceutical Sciences at the University of Ottawa.

• Overview of Governance – objectives, roles, responsibilities & relationships

QIB Board of Trustees

The membership of the Board of Trustees for Quadram Institute Bioscience is drawn from the academic community, the food industry and public representatives and covers a range of skills including business and risk, science and technology and social and ethical responsibility.

Celia Caulcott (Chair)

Dr Celia Caulcott is a highly knowledgeable research and innovation leader, with extensive experience working in and with the biopharmaceuticals industry, agri-food sector and bioindustry more widely.  She is currently the chair of the Board of Trustees of  Quadram Institute Bioscience at Norwich, Vice Chair of the Governing Council of the John Innes Centre and a trustee of the East Malling Trust, where she chairs the Science and Impact Committee.  She is also actively engaged in land management and farming in the Lake District.

Previously Dr Caulcott was Vice-Provost (Enterprise) UCL (University College London) where she was responsible for developing and leading the UCL strategies for innovation and enterprise across all of UCL. This strategy focused on helping the outstanding staff and students of the university to make a difference to society and the world, in particular through embedding a culture of innovation and enterprise across the university. As part of her UCL role she was a non-executive director on UCLB, the highly successful commercialisation business of UCL.

Before this, Celia was the Executive Director, Innovation and Skills at BBSRC, where she was responsible for developing and delivering BBSRC strategy for innovation, and for building its links with the food and agriculture sectors, amongst others. She worked in and with the biopharmaceuticals industry (including Celltech Ltd, ICI Pharmaceuticals, the Wellcome Foundation and various UK early stage biotechs) and the Wellcome Trust on the Human Genome Project.

Celia has a first-class honours degree in Microbiology from Newcastle University and a PhD in pharmaceutical microbiology from Aston University.

Other Trustees

Julian Blow

Professor Julian Blow is Pro Vice-Chancellor for Research and Innovation at the UEA. In this role he aims to enhance and extend the excellence of research at UEA and develop the ways that this has real-world impact outside academia.

Julian joined UEA in 2024 from the University of Dundee, where he had been Dean of the School of Life Sciences. Under his leadership Dundee was ranked the top university for biological sciences research in both REF2014 and REF2021, and was recognised for a range of successful enterprise initiatives in the biosciences.

As Professor of Chromosome Maintenance, Julian is also an active researcher in molecular biology. His research interests span the areas of cell division, chromosome replication and the maintenance of genome integrity. In recognition of his research achievements he has been elected a Fellow of the Academy of Medical Sciences, a Fellow of the Royal Society of Edinburgh, and a Member of the European Molecular Biology Organization. He has served on many national and international scientific committees, including for the BBSRC, CRUK, ERC and NIH. He is currently Chair of the Scientific Committee of the Lister Institute.

Gill Fine

Gill Fine is a Public Health Nutritionist with more than 40 years of experience gained in private, public and voluntary sector organisations. She has a passion for leveraging sound food and nutrition science for public health benefit and helping make healthier eating easier and enjoyable for consumers.

From 2004 to 2010, Gill was Director of Consumer Choice and Dietary Health at the Food Standards Agency. Her role was to provide strategic direction for the development of evidence-based food policies across a wide remit including nutrition, supplements, organics, additives, novel foods, food standards and general food labelling.

In April 2010, she moved to Cornwall to pursue her interests in nutrition and public health on a freelance basis. In addition to her consultancy work she has held various non-executive appointments with several charities, including the British Nutrition Foundation and Diabetes UK. She has also served on several government committees and is a longstanding member of the UK’s Scientific Advisory Committee on Nutrition.

Gill is a Member of the Nutrition Society and gained her MSc Nutrition from Queen Elizabeth College, London in 1981.

Julie Waterfield

Julie Waterfield is Chief Financial Officer at the Royal Veterinary College (RVC), University of London.

Julie joined the RVC in April 2014 having previously worked at Durham University and, prior to that, McGill University in Montreal,  Canada.

As Director of Finance at RVC, she leads the Finance Department and is responsible for the sound oversight and administration of the RVC’s financial affairs. As a member of the Principal’s Advisory Group, Julie ensures financial planning and underpinning financial strategy are robust and support delivery of the Royal Veterinary College’s strategic objectives and ongoing sustainability.

Julie is a Member of the Chartered Institute of Public Finance and Accountancy has holds an honours degree in French and German from the University of Bradford.

Maggie Dallman

Maggie is a Professor and  Associate Provost (Societal Engagement), Founding Academic Director of the Centre for Societal Engagement at Imperial and Professor of Immunology.

Having joined Imperial in 1994 as a lecturer in the Department of Biology, Maggie has held a series of academic responsibilities at Imperial and is now the academic lead on the College’s Societal Engagement Strategy. She is passionate about giving young people the opportunity to reach their potential, believing that education and engagement is central in achieving this goal.

Through Imperial’s Public and Community Engagement teams, as well as through Imperial’s widening participation and outreach work, Maggie’s division provides opportunities in STEM education and research with an emphasis on underserved and underrepresented youth. Maggie’s scientific interests lie in the study of regulation of inflammation and immunity and she has worked for decades in the understanding of immune disorders.

Gary Frost

Gary Frost is Head of the Section for Nutrition Research and leads the Imperial Centre for Translational Nutrition and Food.

His research spans nutrition science, dietary intake, appetite regulation, obesity management, and the relationship between food structure, metabolism, and ageing. His team has made key contributions to understanding the role of gut peptides in appetite regulation.

Current projects investigate how nutrients influence the secretion of appetite-regulating peptides, alongside the fundamental nutritional physiology of energy balance, glucose metabolism, and lipid metabolism. He also leads research into novel technologies that improve the accuracy of dietary assessment. Gary is the lead of the UKRI Ageing Network and Nutrition Sensing Network (AGENTS) and the UKRI Hub RIPEN.

Tim Edwards

In the past 25 years Tim has worked in three sectors: innovative life sciences, education and financial services, with leadership experience gained in both private and listed companies. He is currently Chair of Schroders Capital Global Innovation Trust plc and the Institute for Research in Schools.

Tim has led two companies to exit by trade sale: as Chair of Atopix Therapeutics Limited acquired by Chiesi Farmaceutici S.P.A. in 2016; and President and Chief Executive Officer of Cellzome Inc. acquired by GlaxoSmithKline plc in 2012.

Ian Puddephat

Ian holds a PhD in Horticulture from Nottingham University in the UK. He is an honorary professor at Warwick University and a visiting professor at Cranfield University. Ian is accountable for building a One PepsiCo Science Strategy and scale-able, enterprise-level Science Platforms, across PepsiCo’s Food and Beverage categories.

As the Senior Vice President for Science Platforms and Application Sciences function, he brings extensive scientific expertise, partnering and leadership experience to teams who work across Foods and Beverage in Measurement Sciences, Flavor, Seasoning, Ingredients and Agricultural Sciences.

Paul Quinlan

Paul is a creative business leader with 38 years’ experience in Innovation and business development within the Food & Beverage, Agribusiness and Life Science sectors. After joining Unilever R&D with a PhD in Biochemistry from Bristol, Paul went on to hold many leadership positions in Unilever – directing innovation programmes, new business development, partnership/ecosystem development, strategy and operations.

A focus throughout Paul’s career has been the development of health and nutrition-based innovations and functional foods. He has also published >30 scientific papers in this field. This has included development of a biotechnology derived ingredient for infant nutrition, development of health claims and new functional foods for global tea brands.